|
Proflavine
|
D011370 |
[Topical antiseptic used mainly in wound dressings.
] |
|
Bacteriophage T7
|
B04.123.205.891.230 |
|
|
T-Phages
|
B04.123.205.891 |
|
|
Progeria
|
D011371 |
[An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature graying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.
] |
|
GATA Transcription Factors
|
D050980 |
[A family of transcription factors that contain two ZINC FINGER MOTIFS and bind to the DNA sequence (A/T)GATA(A/G).
] |
|
Progestins
|
D011372 |
[Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
] |
|
Erythroid-Specific DNA-Binding Factors
|
D050981 |
[A group of transcription factors that were originally described as being specific to ERYTHROID CELLS.
] |
|
Myotonic Dystrophy
|
C16.320.577.500 |
|
|
Malignant Atrophic Papulosis
|
C14.907.137.520 |
|
|
GATA1 Transcription Factor
|
D050982 |
[A GATA transcription factor that is specifically expressed in hematopoietic lineages and plays an important role in the CELL DIFFERENTIATION of ERYTHROID CELLS and MEGAKARYOCYTES.
] |
|
Progesterone
|
D011374 |
[The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.
] |
|
Progesterone Reductase
|
D011375 |
[An enzyme that catalyzes the reduction of a 3 beta-hydroxy-delta(5)-steroid to 3-oxo-delta(4)-steroid in the presence of NAD. It converts pregnenolone to progesterone and dehydroepiandrosterone to androstenedione. EC 1.1.1.145.
] |
|
NF-E2 Transcription Factor
|
D050983 |
[A basic-leucine zipper transcription factor that regulates GLOBIN gene expression and is related to TRANSCRIPTION FACTOR AP-1. NF-E2 consists of a small MAF protein subunit and a tissue-restricted 45 kDa subunit.
] |
|
Lymphoma, Large B-Cell, Diffuse
|
C20.683.515.761.480.150.585 |
|
|
NF-E2 Transcription Factor, p45 Subunit
|
D050984 |
[A tissue-specific subunit of NF-E2 transcription factor that interacts with small MAF PROTEINS to regulate gene expression. P45 NF-E2 protein is expressed primarily in MEGAKARYOCYTES; ERYTHROID CELLS; and MAST CELLS.
] |
|
Progesterone-Binding Globulin
|
D011376 |
[A glycoprotein migrating as alpha 1-globulin, molecular weight 70,000 to 120,000. The protein, which is present in increased amounts in the plasma during pregnancy, binds mainly progesterone, with other steroids including testosterone competing weakly.
] |
|
Rhabditida Infections
|
C01.610.335.508.700.700 |
|
|
MafK Transcription Factor
|
D050985 |
[A small Maf protein involved in differentiation of ERYTHROID CELLS. MafK was originally described as the small subunit of the NF-E2 Transcription Factor, but other small MAF PROTEINS also serve as NF-E2 subunits.
] |
|
Proglumide
|
D011377 |
[A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
] |
|
Esters
|
D02.241.400 |
|
